Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamineSCIENTIFIC REPORTSIF3.92022-06-136OAAI
Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative ActivitiesCHEMICAL RESEARCH IN TOXICOLOGYIF3.82018-05-165PREAI
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modificationsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92016-09-0141PREAI
Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injuryTOXICOLOGYIF4.62016-09-0114OAAI
Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stressREDOX REPORTIF7.42016-03-216OAAI
Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation productsTOXICOLOGYIF4.62016-03-0114OAAI
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injuryFREE RADICAL BIOLOGY AND MEDICINEIF8.22014-09-0132OAAI
Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis PathwaysJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82012-11-0152PREAI
Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicityTOXICOLOGYIF4.62011-11-0145PREAI
Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicityFREE RADICAL BIOLOGY AND MEDICINEIF8.22011-02-0147PREAI
Synthesis and Initial in Vitro Evaluations of Novel Antioxidant Aroylhydrazone Iron Chelators with Increased Stability against Plasma HydrolysisCHEMICAL RESEARCH IN TOXICOLOGYIF3.82011-01-0758PREAI
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicityARCHIVES OF TOXICOLOGYIF6.92010-11-0322PREAI
Comparison of Clinically Used and Experimental Iron Chelators for Protection against Oxidative Stress-Induced Cellular InjuryCHEMICAL RESEARCH IN TOXICOLOGYIF3.82010-06-0368PREAI
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell deathBRITISH JOURNAL OF CANCERIF6.82009-07-2153OAAI
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazoneBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2951OAAI
Direct administration of rutin does not protect against catecholamine cardiotoxicityTOXICOLOGYIF4.62009-01-0113PREAI
The Novel Iron Chelator, 2-Pyridylcarboxaldehyde 2-Thiophenecarboxyl Hydrazone, Reduces Catecholamine-Mediated Myocardial ToxicityCHEMICAL RESEARCH IN TOXICOLOGYIF3.82008-12-1229PREAI
HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomersJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12008-09-0134PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向